MONA SPEAK: Open Payments
NPI 1366682551 · PENNINGTON GAP, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$126 in 8 payments from 4 companies in 2025. Trend: 2023 $87 · 2024 $97 · 2025 $126
Food & beverage: $126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $48 |
| Novo Nordisk Inc | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: XIFAXAN, VRAYLAR, BREZTRI, Rybelsus, QULIPTA, Ozempic, UBRELVY.
Industry payments across VA — which companies pay providers there.
